Skip to main content

Watson's Mesalazine API Production Pursuing DMF Registration in the EU and Japan

Watson is a trusted leader in the production of mesalazine active pharmaceutical ingredients or API, leveraging advanced technology and a robust regulatory framework to ensure high-quality supply for global markets. Plant under Watson is actively pursuing EU Certificate of Suitability and Drug Master File registration in Japan.
https://www.youtube.com/watch?v=VDI6S7IV5KQ
Labels:

Comments

Post a Comment

Popular posts from this blog

BCB (Benzocyclobutene): — Watson International Enables the Transition from Concept to Scalable Application

Benzocyclobutene (BCB) is an organic compound with a rigid molecular structure composed of a conjugated benzene ring and a four-membered ring. Its excellent thermal stability and electrical properties have made it a highly promising candidate for next-generation electronic materials. Historically, its industrial adoption has been constrained by high production costs, complex purification processes, and limited output. However, with growing demand in high-end applications and recent advances in upstream technology, BCB is now poised for industrial-scale deployment. Material Properties and Structural Advantages BCB (C₈H₈) is a non-polar molecule, free of ester, carboxyl, or amide groups, giving it excellent dielectric properties and low moisture absorption. Its dielectric constant (Dk) and dissipation factor (Df) remain stable across wide temperature and frequency ranges—key metrics for ensuring signal integrity in high-frequency, high-speed communication systems. Unlike conventional m...
Post a Comment
Read more

Overcoming the "Choke Points" in Semaglutide Side Chain Synthesis with Core Technologies to Enable Efficient GLP-1 Drug Manufacturing

Semaglutide, a groundbreaking product in the GLP-1 drug class, owes its extended half-life and enhanced receptor affinity largely to its unique side chain, Ste-Glu-AEEA-AEEA-OSU (CAS: 1169630-40-3) . This side chain covalently modifies the peptide backbone, significantly improving pharmacokinetics and therapeutic performance. However, its complex structure presents two critical synthetic challenges: Precise Assembly of Repetitive AEEA Units: The side chain features consecutive AEEA (aminoethoxyethoxyacetic acid) units, which require stepwise coupling via highly activated intermediates (e.g., AEEA-AEEA). Any impurities or deviations compromise downstream reaction efficiency and may trigger irreversible byproducts. Stereochemistry and Stability of Glutamic Acid (Glu): The glutamic acid component must maintain strict L-configuration, and its carboxyl groups require directional protection (e.g., OtBu) to preserve biological activity. Leveraging deep expertise in peptide chemistry a...
Post a Comment
Read more

Empowering Innovation: ChemWhat's Organic Optoelectronic Ecosystem (Video)

A standout component of this lineup is the Fullerene C60 derivative, PC61BM. Widely recognized as a benchmark material, PC61BM plays a pivotal role not only in Organic Solar Cells (OSCs) but also in Perovskite Solar Cells (PSCs), where it functions as a highly efficient Electron Transport Layer (ETL) and grain boundary passivator. To address the varied requirements of universities, R&D centers, and commercial manufacturers, ChemWhat has standardized this product into two distinct purity levels: 99.5% for general research and 99.9% for high-precision device fabrication.
Post a Comment
Read more